Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2021 May 10.
Published in final edited form as: J Neurol Sci. 2019 Mar 29;400:194–198. doi: 10.1016/j.jns.2019.03.026

The Sub-Saharan Africa Conference on Stroke (SSACS): An idea whose time has come

Mayowa Owolabi a,b,f,*, Fred Stephen Sarfo c, Rufus Akinyemi b,f, Mehari Gebreyohanns d, Bruce Ovbiagele e
PMCID: PMC8108722  NIHMSID: NIHMS1688505  PMID: 30991160

Abstract

Stroke is a leading cause of global morbidity and mortality. Sub-Saharan Africa (SSA), where an unprecedented rise in stroke burden is currently raging, has the highest age-standardized stroke incidence, stroke prevalence, and stroke mortality rates. This is in sharp contrast to the relative decline in stroke incidence in high-income countries over the past four decades through better awareness and control of vascular risk factors. Compared to other groups, Africans tend to have a higher risk of stroke, higher percentage of the hemorrhagic type and much poorer outcomes. Indeed, stroke levies a heavy toll on the developing SSA economy by affecting a relatively younger age group. In this commentary, we examine the disproportionately high burden of stroke in the setting of grossly inadequate resources and evidence-based interventions. We propose an annual pan-regional stroke conference (starting in 2020) to harness global resources and local talent with the goal of galvanizing action to tackle this escalating burden. We anticipate that a successful conference series could become a rallying point for the eventual establishment of an African Stroke Organization.

Keywords: Stroke, Africans, Sub-Saharan Africa, Conference

1. Introduction

Stroke is a leading cause of death, disability and dementia globally [1,2]. Sub-Saharan Africa (SSA), where an unprecedented rise in stroke burden is currently raging, has the highest age-standardized stroke incidence (up to 316 per 100,000) rate, and prevalence (up to 14.6 per 1000 population) [3], with a 3-year mortality rate of up to 84% [4]. This is in sharp contrast to the relative decline in stroke incidence in high-income countries over the past four decades through better awareness and control of vascular risk factors [13,5]. Compared to other groups, Africans tend to have a higher risk of stroke, higher percentage of the hemorrhagic type, much poorer outcomes and associated with a high burden of psycho-social post-stroke co-morbidities [613]. Indeed, stroke levies a heavy toll on the developing SSA economy by affecting a relatively younger age group [14]. In this commentary, we examine the disproportionately high burden of stroke in the setting of grossly inadequate resources and evidence-based interventions. We propose a pan-regional conference to harness global resources and galvanize action to tackle the escalating burden.

2. Projected burden of stroke and its risk factors in SSA

Current projections suggest the burden of stroke in SSA will escalate over coming decades due to adoption of western lifestyles, increasing urbanization, lack of risk awareness and poor healthcare infrastructure [4]. These factors are jointly responsible for the increasing burden of vascular diseases which are also risk factors for stroke in SSA [4]. Available evidence show the number of people in SSA with hypertension will increase by 68% from 75 million in 2008 to 126 million in 2025 [5]. Thus developing interventions to reduce the growing burden of stroke based on research conducted in SSA should be a major priority. This is because, both the Global Burden of Disease [15] and INTERSTROKE [16] studies showed geographical variations in relevance of traditional stroke risk factors. Moreover, the genetic architecture of a population may play an instrumental role in risk factor predisposition and ultimately the manifestation of stroke. So, evidence generated from outside the region may not be directly applicable.

3. Low research output from SSA

Despite the disproportionately higher burden of non-communicable diseases (NCDs) in SSA compared to the rest of the world, research output from scholars in SSA is unacceptably low, accounting for < 1% of the world’s research output compared with its share of global population at 12%; compared to those from low to middle-income countries in other regions of the world such as Vietnam and Malaysia [17]. Furthermore, the proportion of research conducted by African scholars is abysmally low (3.9%) with over 70% being attributed to collaborating scholars from western countries. Most importantly, there is little intra- and inter-African collaborative research, representing only 0.9%–2.9% of the total research output from Africa. Such low interregional collaboration has resulted in lack of adoption of evidence-based and context-driven practices to mitigate the burden of NCDs in the region. In a report by the Global Forum for Health Research, Council on Health Research for Development and UNICEF/UNDP/World Bank/WHO Special Program for Research and Training in Tropical Diseases proposed that in addition to improving conditions of health service, fostering career pathways is an important and potentially implementable solution for strengthening research capacity in SSA [18].

Strengthening research capacity is crucial to unravelling the role of genes and their interactions with environmental factors for stroke occurrence and developing tailored interventions for prevention and treatment of stroke and other cardiovascular diseases in SSA. Stroke (including recurrent stroke) is highly preventable via risk factor control [19,20], but a dearth of resources in SSA to administer acute stroke treatment, underscores the notion that while systems of acute stroke care need to be developed, control of stroke risk factors will likely be the most viable strategy for mitigating the escalating SSA stroke epidemic [21,22].

The largest study of stroke on the continent, Stroke Investigative Research and Education Network (SIREN), has examined the dominant risk factors for stroke which can be targeted for prevention [23]. SIREN is a transnational, multicenter, hospital and community-based study involving 4000 cases and 4000 controls recruited from multiple sites (academic safety net hospitals) in Ghana and Nigeria [23]. Cases were hospital-based patients with first stroke within 10 days of onset in whom neurovascular imaging is performed. Etiological and topographical stroke subtypes are documented for all cases. Controls were hospital- and community-based participants, matched to cases on the basis of gender, ethnicity, and age (± 5 years) [23]. Published studies emanating from SIREN have validated stroke screening tools [2426], developed phenotyping software [27], assessed cardiac indices [28,29], and level of community engagement [30,31]. The 12 topmost modifiable risk factors for all stroke in descending order of population attributable risk were hypertension, dyslipidemia, regular meat consumption, elevated waist-to-hip ratio, diabetes mellitus, income level > $100/month, stress, cardiac disease, added salt at table, and tobacco use, while green leafy vegetable consumption and physical activity were protective [32]. Whereas the factors identified in SIREN could be targeted for stroke prevention, there are numerous barriers mitigating against the control of these risk factors.

4. Barriers against stroke control in SSA

Although sustained adherence to medications for risk factor control will reduce stroke events [3335], lack of adherence is a leading modifiable barrier to risk factor control [3639]. Patients whose beliefs are discordant with conventional biomedical concepts have poorer risk factor control than those with concordant beliefs [4045]. Furthermore, predictors of poor adherence to medication in SSA have been linked to poor patient-provider communication [4649]. A study in Nigeria found a major reason for non-adherence to anti-hypertensive drugs was that clinicians didn’t provide appropriate guideline based treatment plans (60%) [40].

In turn, ability to provide optimal services by health care workers is influenced by increased patient load, overall rise in workload, and shortage of workers. With a health worker-to-population ratio 0.8 per 10,000 inhabitants, there are clear indications that most SSA countries will not cope with the high demand of caring for chronic diseases. Of relevance to stroke, the neurologist-population ratio in SSA ranges from 1 per 162,885 persons to none in 11 countries (vs. 1 per 29,200 persons in the US) [50], and there are 2.5 physiotherapists and 2 occupational therapists per 100,000 people served. A key issue is the brain drain that has plagued SSA [51], and led to a shortage of health workers available to provide stroke prevention and treatment at available care systems [5,52,53].

5. Potential solutions to stroke prevention and treatment in SSA

The contextually unique landscape of SSA with socioeconomic obstacles, cultural barriers, uncoordinated care, and shortage of physicians [50,54], will require development of culturally-appropriate, affordable, and sustainable interventions, which can be readily scaled up. First, it is imperative to strengthen the health systems in SSA. The World Health Organization (WHO) suggests that health systems should carry out basic functions: provide services; develop health workers; provide equitable access to essential medical products; ensure use of reliable information on health determinants and systems performance; and ensure health system leadership and governance [55]. Furthermore, as chronic disease patients are actually often their own primary carers, their needs and preferences must be taken into account in the development of management plans [56]. Therefore, encounters between patients and their health care professionals become a critical intersection for information exchange, decision-making and motivation [57]. Stroke is a prime example of a common chronic disease that causes substantial morbidity and mortality, and requires long-term medical management and coordinated support. It is believed that informed patients improve their decisions by collaborating with their health-care providers toward a common goal. This results in increased patient involvement leading to a positive effect on the health outcomes [58]. Poor knowledge of chronic diseases leads to problematic treatment practices such as healer shopping within traditional healing systems [59].

Another potential solution to limited healthcare access in SSA is task-sharing or task-shifting. Task sharing involves training non-physician healthcare workers to perform tasks traditionally undertaken by physicians [60]. Task-shifting can potentially result in cost and physician time savings without compromising the quality of care or health outcomes for patients [6163]. A study from Rwanda showed that task-shifting from a physician-centered to a nurse-centered model reduced the demand on physician time by 76% [64]. The WHO in consultation with a wide range of experts has formulated a set of 22 recommendations that provide guidance to the task-shifting approach [65].

Furthermore, an important and feasible, but underutilized method of monitoring and supervising stroke care delivery and remote training of non-specialist healthcare workers, is mobile phone technology [66]. SSA has a tele-density of up to 95% [67]. Moreover, specialized care in SSA is restricted to a few tertiary centers with limited access to care for the majority of the population who live in rural areas. In high incomes countries, tele-health has been an effective model for bridging the rural-urban gap in access to specialized care services [68], for several major neurological disorders including stroke [6883], a model which could be adopted, refined and culturally-tailored for SSA. The combination of high burden of NCDs, low levels of access to healthcare services, and high mobile phone penetration highlights the potential of using mobile & tele-technology to provide access to evidenced-based healthcare in SSA. A pilot trial in Ghana has recently demonstrated the feasibility of utilizing m-health interventions under nurse guidance for blood pressure control among recent stroke survivors [8486]. Further research has shown some promising results for tele-rehabilitation after stroke [8790] and other on-going trials are exploring other interventions such as use of cardiovascular polypills to improve medication adherence after stroke in SSA [91,92].

Crucially, social networks can serve to greatly reduce the sense of isolation experienced by scientists [93]. In particular, dedicated forums can permit the integration of technologies to create opportunities to meet and discuss science and serve as an effective medium for teaching and mentoring [93]. Thus, we propose convening a scientific forum that will focus on guiding/encouraging both the current and next generation of African Scholars to work in teams to develop research plans and evidenced based solutions targeted at understanding and reducing the growing burden of stroke in SSA. Appropriate models of research will be required to test dynamic, multidimensional interventions that triangulate on patients, providers, and communities, which are continuously improved with feedback from rapid-cycle measurement of population health outcomes [94]. An annual gathering of researchers, clinicians, and policy makers from various scientific and professional backgrounds, which leverages and contextually adapts existing knowledge dissemination channels and key partnerships, could help to expose research gaps, highlight promising work, foster surveillance, tackle ethical, legal and social barriers; inform policy makers, recognize achievement, and inspire greater interest among post-doctoral scholars/junior faculty to pursue careers in this field; all thereby catalyzing the development and successful implementation of interventions aimed at enhancing stroke outcomes in SSA. Fostering the successful development of the next generation of stroke researchers in SSA is crucial to resolving this growing challenge.

6. Conference proposal

The Sub-Saharan Africa Conference on Stroke (SSACS), will be a one-day annual scientific forum focused on cerebrovascular disease in SSA, with the overarching goal of bringing together key stakeholders, identifying gaps in knowledge, setting priorities for stroke care delivery and research, fostering collaborations, and accelerating translation of research findings to improve stroke outcomes in the region. SSACS would be intended to as a collaborative initiative with the World Stroke Organization, World Hypertension League, World Federation of Neurology, African Union, African Academy of Sciences, World Federation for Neurorehabilitation, African governmental agencies, local academic institutions, local teaching hospitals, and Stroke Support Groups. SSACS 2020 will be held in Bahir Dar, Ethiopia. We will seek various partners will provide financial and in-kind logistics, space, and personnel to support successful execution of SSACS. SSACS 2020 will focus on stroke epidemiology, community awareness, and stakeholder engagement in SSA.

SSACS will award travel scholarships to 20 promising Post-Doctoral Scholars in SSA (Young Investigators) committed to careers in stroke research. Scholars will present their work at SSACS. Proposed eligible Young Investigator award participants would include: 1) Residency fellows (neurology, neurosurgery, internal medicine, cardiologists); 2) Post-doc allied health professionals (nursing, pharmacy, physical therapy, occupational therapy, speech therapy, nutritionists); 3) Post-doc researchers (epidemiologists, health services researchers). A Poster Session will invite abstract submissions from early career SSA investigators (post-doc scholars or individuals within 3 years of a first faculty appointment) with an interest in stroke research. This event will be open to all SSACS attendees and will provide a dedicated setting for the participants to practice presenting and receiving feedback on their research. Equally important, it provides an excellent opportunity for networking. SSACS will also feature Early Career Development & Stroke Support Organization (SSO) Sessions. Networking functions will involve scheduled events at the Symposium. Finally, to evaluate effectiveness of SSACS we will assess: 1) Number of Attendees; 2) Attendee Engagement; & 3) Selected Young Investigator Award Scholar Achievements (publications, presentations, positions, awards, and so forth).

The conference proposal is consistent with goals of governmental and non-governmental public health, research, and professional agencies to identify and address health disparities, as well as to foster a capable academic/professional workforce. SSACS is a novel initiative due to: 1) firm commitment from a cadre of distinguished academicians experienced with stroke research and practice in SSA, most of whom are African; 2) robust in-person and online networking activities aimed at enhancing professional advancement; 3) comprehensive program evaluation methods; 4) focus on a single major disease entity, stroke within the context of cardiovascular diseases which are its risk factors, which together substantially burdens SSA and can be studied from a variety of scientific and professional disciplines; 5) close collaboration with several prominent global and regional non-governmental and governmental agencies, to provide an enrichment of events geared at facilitating discourse during SSACS and broadening the exposure of SSA trainees to important opportunities designed to lead to a successful research career in stroke research. Although it is recognized that funding is year to year, it is anticipated that this conference will grow both in length and scope to encompass more budding and seasoned experts from increasingly diverse disciplines all bound by an interest in resolving the growing epidemic of stroke in SSA. In this way a comprehensive and cumulative look at stroke in SSA will occur, and a core curriculum will be realized. We anticipate that beyond 2022, likely accelerated by SSACS-related activities, an African Stroke Organization would be established, and will take on the responsibility of holding future annual conferences on stroke in SSA.

Acknowledgement

MO, BO, RA and FS are supported by U54 HG007479 and R01NS107900 from the National Institutes of Health.

References

  • [1].Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, et al. , Heart disease and stroke statistics-2019 update: a report from the american heart association, Circulation 139 (2019) e56–e66. [DOI] [PubMed] [Google Scholar]
  • [2].Pandian JD, Gall SL, Kate MP, Silva GS, Akinyemi RO, Ovbiagele BI, et al. , Prevention of stroke: a global perspective, Lancet 392 (2018) 1269–1278. [DOI] [PubMed] [Google Scholar]
  • [3].Ezejimofor MC, Uthman OA, Maduka O, Ezeabasili AC, Onwuchekwa AC, Ezejimofor BC, et al. , Stroke survivors in Nigeria: a door-to-door prevalence survey from the Niger delta region, J. Neurol. Sci 372 (2017) 262–269. [DOI] [PubMed] [Google Scholar]
  • [4].BeLue R, Okoror TA, Iwelunmor J, Taylor KD, Degboe AN, Agyemang C, et al. , An overview of cardiovascular risk factor burden in sub-saharan African countries: a socio-cultural perspective, Glob. Health 5 (2009) 10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [5].Mayosi BM, The 10 ‘best buys’ to combat heart disease, diabetes and stroke in Africa, Heart 99 (2013) 973–974. [DOI] [PubMed] [Google Scholar]
  • [6].Sarfo FS, Awuah DO, Nkyi C, Akassi J, Opare-Sem OK, Ovbiagele B, Recent patterns and predictors of neurological mortality among hospitalized patients in Central Ghana, J. Neurol. Sci 363 (2016) 217–224. [DOI] [PubMed] [Google Scholar]
  • [7].Sarfo FS, Akassi J, Awuah D, Adamu S, Nkyi C, Owolabi M, Ovbiagele B, Trends in stroke admission & mortality rates from 1983 to 2013 in Central Ghana, J. Neurol. Sci 357 (1–2) (2015) 240–245. [DOI] [PubMed] [Google Scholar]
  • [8].Owolabi MO, Akarolo-Anthony S, Akinyemi R, et al. , The burden of stroke in Africa: a glance at the present and a glimpse into the future, Cardiovasc. J. Afr 26 (2 Suppl 1) (March, 2015) S27–S38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [9].Sarfo FS, Akassi J, Kyem G, Adamu S, Awuah D, Kantanks OS, et al. , Long-term outcomes of stroke in a Ghanaian outpatient clinic, J. Stroke Cerebrovasc. Dis 27 (3) (2018) 1090–1099. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [10].Sarfo FS, Jenkins C, Singh A, Owolabi M, Ojagbemi A, Adusei N, Saulson R, Ovbiagele B, Post-stroke depression in Ghana: characteristics and correlates, J. Neurol. Sci 379 (2017) 261–265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [11].Sarfo FS, Akassi J, Adamu S, Obese V, Ovbiagele B, Burden and predictors of vascular cognitive impairment among long-term Ghanaian stroke survivors, J. Stroke Cerebrovasc. Dis 26 (11) (2017) 2553–2562. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [12].Sarfo FS, Nichols M, Qanungo S, Teklehaimanot A, Singh A, Mensah N, et al. , Stroke-related stigma among west Africans: patterns and predictors, J. Neurol. Sci 375 (2017) 270–274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [13].Sarfo FS, Berchie P, Singh A, Nichols M, Agyei-Frimpong M, Jenkins C, et al. , Prevalence, trajectory, and predictors of poststroke fatigue among Ghanaians, J. Stroke Cerebrovasc. Dis (February 20, 2019) (pii: S1052–3057(19)30046–1). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [14].Sarfo FS, Ovbiagele B, Gebregziabher M, Wahab K, Akinyemi R, Akpalu A, et al. , Stroke among young West Africans: evidence from the SIREN (Stroke Investigative Research and Educational Network) large multisite case-control study, Stroke 49 (5) (2018) 1116–1122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [15].Feigin VL, Roth GA, Naghavi M, et al. , Global burden of stroke and risk factors in 188 countries, during 1990–2013: a systematic analysis for the global burden of disease study 2013, Lancet Neurol 15 (9) (2016) 913–924. [DOI] [PubMed] [Google Scholar]
  • [16].O’Donnell MJ, Chin SL, Rangarajan S, et al. , Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study, Lancet 388 (10046) (2016) 761–775. [DOI] [PubMed] [Google Scholar]
  • [17].Ghaffar DA, IJsselmuiden C, Zicker F, Changing Mindsets: Research Capacity Strengthening in Low-and Middle-Income Countries: Council on Health Research for Development (Cohred), (2008).
  • [18].Lan G, Blom A, Kamalski J, Lau G, Baas J, Adil M, A Decade of Development in Sub-Saharan African Science, Technology, Engineering & Mathematics Research Washington, D.C, (2014). [Google Scholar]
  • [19].Furie KL, Kasner SE, Adams RJ, Albers GW, Bush RL, Fagan SC, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association. Stroke 42:227–276. [DOI] [PubMed] [Google Scholar]
  • [20].Sacco RL, Boden-Albala B, Gan R, Chen X, Kargman DE, Shea S, et al. , Stroke incidence among white, black, and hispanic residents of an urban community: the northern Manhattan stroke study, Am. J. Epidemiol 147 (1998) 259–268. [DOI] [PubMed] [Google Scholar]
  • [21].Smith SM, Mensah GA, Population aging and implications for epidemic cardiovascular disease in sub-saharan Africa, Ethn. Dis 13 (2003) S77–S80. [PubMed] [Google Scholar]
  • [22].Maimela E, Van Geertruyden JP, Alberts M, Modjadji SE, Meulemans H, Fraeyman J, et al. , The perceptions and perspectives of patients and health care providers on chronic diseases management in rural South Africa: a qualitative study, BMC Health Serv. Res 15 (2015) 143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [23].Akpalu A, Sarfo FS, Ovbiagele B, Akinyemi R, Gebregziabher M, Obiako R, et al. , Phenotyping stroke in sub-saharan Africa: stroke investigative research and education network (siren) phenomics protocol, Neuroepidemiology 45 (2015) 73–82. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [24].Sarfo FS, Gebregziabher M, Ovbiagele B, Akinyemi R, Owolabi L, Obiako R, et al. , Validation of the 8-item questionnaire for verifying stroke free status with and without pictograms in three west African languages, eNeurologicalSci 3 (2016) 75–79. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [25].Sarfo F, Gebregziabher M, Ovbiagele B, Akinyemi R, Owolabi L, Obiako R, et al. , Multilingual validation of the questionnaire for verifying stroke-free status in west africa, Stroke 47 (2016) 167–172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [26].Sarfo FS, Gyamfi RA, Adamu S, Sarfo-Kantanka O, Owolabi M, Ovbiagele B, Administration of a pictorial questionnaire to screen for stroke among patients with hypertension or diabetes in rural Ghana, J. Neurol. Sci 15 (2017) 289–294. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [27].Owolabi M, Ogbole G, Akinyemi R, Salaam K, Akpa O, Mongkolwat P, et al. , Development and reliability of a user-friendly multicenter phenotyping application for hemorrhagic and ischemic stroke, J. Stroke Cerebrovasc. Dis 26 (2017) 2662–2670. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [28].Adeoye AM, Ogah OS, Ovbiagele B, Akinyemi R, Shidali V, Agyekum F, et al. , Prevalence and prognostic features of ecg abnormalities in acute stroke: findings from the siren study among africans, Glob. Heart 12 (2017) 99–105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [29].Adeoye AM, Ovbiagele B, Kolo P, Appiah L, Aje A, Adebayo O, et al. , Exploring overlaps between the genomic and environmental determinants of lvh and stroke: a multicenter study in west africa, Glob. Heart 12 (2017) 107–113 ( e105). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [30].Jenkins C, Arulogun OS, Singh A, Mande AT, Ajayi E, Benedict CT, et al. , Stroke investigative research and education network: community engagement and outreach within phenomics core, Health Educ. Behav 43 (2016) 82S–92S. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [31].Singh A, Jenkins C, Calys-Tagoe B, Arulogun OS, Sarfo S, Ovbiagele B, et al. , Stroke investigative research and education network: public outreach and engagement, J. Community Med. Health Educ 7 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [32].Owolabi M, Sarfo F, Akinyemi R, Gebregziabher M, Akpa O, Akpalu A, Wahab K, Obiako R, Owolabi L, Ovbiagele B, on behalf of SIREN Team as part of H3Africa Consortium, Dominant risk factors for stroke among west Africans: findings from the siren large multisite study, Lancet Glob. Health 6 (4) (2018) e436–e446 (In Press). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [33].Cramer JA, Benedict A, Muszbek N, Keskinaslan A, Khan ZM, The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review, Int. J. Clin. Pract 62 (2008) 76–87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [34].Ishisaka DY, Jukes T, Romanelli RJ, Wong KS, Schiro TA, Disparities in adherence to and persistence with antihypertensive regimens: an exploratory analysis from a community-based provider network, J. Am. Soc. Hypertens 6 (2012) 201–209. [DOI] [PubMed] [Google Scholar]
  • [35].Romanelli RJ, Schiro TA, Jukes T, Wong KS, Ishisaka DY, Disparities in blood pressure control within a community-based provider network: an exploratory analysis, Ann. Pharmacother 45 (2011) 1473–1482. [DOI] [PubMed] [Google Scholar]
  • [36].Krousel-Wood M, Joyce C, Holt E, Muntner P, Webber LS, Morisky DE, et al. , Predictors of decline in medication adherence: results from the cohort study of medication adherence among older adults, Hypertension 58 (2011) 804–810. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [37].Dusing R, Overcoming barriers to effective blood pressure control in patients with hypertension, Curr. Med. Res. Opin 22 (2006) 1545–1553. [DOI] [PubMed] [Google Scholar]
  • [38].Borzecki AM, Oliveria SA, Berlowitz DR, Barriers to hypertension control, Am. Heart J 149 (2005) 785–794. [DOI] [PubMed] [Google Scholar]
  • [39].Andrade SE, Gurwitz JH, Field TS, Kelleher M, Majumdar SR, Reed G, et al. , Hypertension management: the care gap between clinical guidelines and clinical practice, Am. J. Manag. Care 10 (2004) 481–486. [PubMed] [Google Scholar]
  • [40].Amira CO, Okubadejo NU, Factors influencing non-compliance with anti-hypertensive drug therapy in nigerians, Niger. Postgrad. Med. J 14 (2007) 325–329. [PubMed] [Google Scholar]
  • [41].Heurtin-Roberts S, Reisin E, The relation of culturally influenced lay models of hypertension to compliance with treatment, Am. J. Hypertens 5 (1992) 787–792. [DOI] [PubMed] [Google Scholar]
  • [42].Horne R, Weinman J, Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness, J. Psychosom. Res 47 (1999) 555–567. [DOI] [PubMed] [Google Scholar]
  • [43].Horne R, Patients’ beliefs about treatment: the hidden determinant of treatment outcome? J. Psychosom. Res 47 (1999) 491–495. [DOI] [PubMed] [Google Scholar]
  • [44].Ogedegbe G, Harrison M, Robbins L, Mancuso CA, Allegrante JP, Reasons patients do or do not take their blood pressure medications, Ethn. Dis 14 (2004) 158. [PubMed] [Google Scholar]
  • [45].Ogedegbe G, Harrison M, Robbins L, Mancuso CA, Allegrante JP, Barriers and facilitators of medication adherence in hypertensive African americans: a qualitative study, Ethn. Dis 14 (2004) 3–12. [PubMed] [Google Scholar]
  • [46].Jackson IL, Adibe MO, Okonta MJ, Ukwe CV, Medication adherence in type 2 diabetes patients in Nigeria, Diabetes Technol. Ther 17 (2015) 398–404. [DOI] [PubMed] [Google Scholar]
  • [47].Gellad WF, Grenard JL, Marcum ZA, A systematic review of barriers to medication adherence in the elderly: looking beyond cost and regimen complexity, Am. J. Geriatr. Pharmacother 9 (2011) 11–23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [48].Yusuff KB, Obe O, Joseph BY, Adherence to anti-diabetic drug therapy and self management practices among type-2 diabetics in Nigeria, Pharm. World Sci 30 (2008) 876–883. [DOI] [PubMed] [Google Scholar]
  • [49].Adisa R, Fakeye TO, Fasanmade A, Medication adherence among ambulatory patients with type 2 diabetes in a tertiary healthcare setting in southwestern Nigeria, Pharm. Pract 9 (2011) 72–81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [50].Owolabi MO, Bower JH, Ogunniyi A, Mapping Africa’s way into prominence in the field of neurology, Arch. Neurol 64 (2007) 1696–1700. [DOI] [PubMed] [Google Scholar]
  • [51].Hagopian A, Thompson MJ, Fordyce M, Johnson KE, Hart LG, The migration of physicians from sub-saharan Africa to the United States of America: measures of the African brain drain, Hum. Resour. Health 2 (2004) 17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [52].Dovlo D, The Brain Drain and Retention of Health Professionals in Africa. Case Studies Prepared for Regional Training Conference: Improving Tertiary Education in Sub-Saharan Africa: Things that Work! Accra, 23–25 September 2003, Available at: http://www.worldbank.org/afr/teia/conf_0903/dela_dovlo.Pd. [Google Scholar]
  • [53].Chen L, Evans T, Anand S, Boufford JI, Brown H, Chowdhury M, et al. , Human resources for health: overcoming the crisis, Lancet 364 (2004) 1984–1990. [DOI] [PubMed] [Google Scholar]
  • [54].Whiting DR, Hayes L, Unwin NC, Diabetes in Africa. Challenges to health care for diabetes in Africa, J. Cardiovasc. Risk 10 (2003) 103–110. [DOI] [PubMed] [Google Scholar]
  • [55].Adam T, Hsu J, de Savigny D, Lavis JN, Rottingen JA, Bennett S, Evaluating health systems strengthening interventions in low-income and middle-income countries: are we asking the right questions? Health Policy Plan 27 (Suppl. 4) (2012) iv9–19. [DOI] [PubMed] [Google Scholar]
  • [56].Thorne SE, Harris SR, Mahoney K, Con A, McGuinness L, The context of health care communication in chronic illness, Patient Educ. Couns 54 (2004) 299–306. [DOI] [PubMed] [Google Scholar]
  • [57].Haidet P, Kroll TL, Sharf BF, The complexity of patient participation: lessons learned from patients’ illness narratives, Patient Educ. Couns 62 (2006) 323–329. [DOI] [PubMed] [Google Scholar]
  • [58].Kangovi S, Grande D, Carter T, Barg FK, Rogers M, Glanz K, et al. , The use of participatory action research to design a patient-centered community health worker care transitions intervention, Healthcare 2 (2014) 136–144. [DOI] [PubMed] [Google Scholar]
  • [59].de-Graft Aikins A, Boynton P, Atanga LL, Developing effective chronic disease interventions in Africa: insights from ghana and cameroon, Glob. Health 6 (2010) 6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [60].Lekoubou A, Awah P, Fezeu L, Sobngwi E, Kengne AP, Hypertension, diabetes mellitus and task shifting in their management in sub-saharan Africa, Int. J. Environ. Res. Public Health 7 (2010) 353–363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [61].Callaghan M, Ford N, Schneider H, A systematic review of task- shifting for hiv treatment and care in Africa, Hum. Resour. Health 8 (2010) 8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [62].Abegunde DO, Shengelia B, Luyten A, Cameron A, Celletti F, Nishtar S, et al. , Can non-physician health-care workers assess and manage cardiovascular risk in primary care? Bull. World Health Organ 85 (2007) 432–440. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [63].Joshi R, Alim M, Kengne AP, Jan S, Maulik PK, Peiris D, et al. , Task shifting for non-communicable disease management in low and middle income countries–a systematic review, PLoS One 9 (2014) e103754. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [64].Mdege ND, Chindove S, Ali S, The effectiveness and cost implications of task-shifting in the delivery of antiretroviral therapy to hiv-infected patients: a systematic review, Health Policy Plan 28 (2013) 223–236. [DOI] [PubMed] [Google Scholar]
  • [65].Increasing access to health workers in remote and rural areas through improved retention, Global Policy Recommendations, 2010. Geneva. [PubMed] [Google Scholar]
  • [66].Bee PE, Bower P, Lovell K, Gilbody S, Richards D, Gask L, et al. , Psychotherapy mediated by remote communication technologies: a meta-analytic review, BMC Psychiatry 8 (2008) 60. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [67].Pew Ressearch Center, Cell phones in Africa, vol. 2016, (2016). [Google Scholar]
  • [68].Demaerchalk BM, Raman R, Ernstrom K, Meyer BC, Efficacy of telemedicine for stroke: pooled analysis of the stroke team remote evaluation using a digital observation camera (STRokE DOC) and STRokE DOC Arizona telestroke trials, Telemed. J. E-Health 18 (2012) 230–237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [69].Demaerchalk BM, Hwang HM, Leung G, Cost analysis review of stroke centers, telestroke, and rt-PA, Am. J. Manag. Care 16 (2010) 537–544. [PubMed] [Google Scholar]
  • [70].Lai F, Stroke networks based on robotic telepresence, J. Telemed. Telecare 15 (2009) 135–136. [DOI] [PubMed] [Google Scholar]
  • [71].Hess DC, Wang S, Hamilton W, Lee S, Pardue C, Waller JL, et al. , REACH: clinical feasibility of a rural telestroke network, Stroke 36 (2005) 2018–2020. [DOI] [PubMed] [Google Scholar]
  • [72].Switzer JA, Hall C, Gross H, Waller J, Nichols FT, Wang S, et al. , A web-based telestroke system facilitates rapid treatment of acute ischemic stroke patients in rural emergency departments, J. Emerg. Med 36 (2009) 12–18. [DOI] [PubMed] [Google Scholar]
  • [73].Meyer BC, Raman R, Hemmen T, Obler R, Zivin JA, Rao R, et al. , Efficacy of site-independent telemedicine in the STRokE DOC trial: a randomized, blinded, prospective study, Lancet Neurol 7 (2008) 787–795. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [74].Sairanen T, Soinila S, Nikkanen M, Rantanen K, Mustanoja S, Farkkila M, et al. , Finnish Telestroke Task Force, Two years of Finnish Telestroke: thrombolysis at spokes equal to that at the hub, Neurology 80 (2013) 332–338. [DOI] [PubMed] [Google Scholar]
  • [75].Audebert HJ, Schenkel J, Heuschmann PU, Bogdahn U, Haberl RL, Telemedic Pilot Project for Integrative Stroke Care Group, Effects of the implementation of a telemdical stroke network: the Telemedic Pilot Project for Integrative Stroke Care (TEMPiS) in Bavaria, Germany, Lancet Neurol 5 (2006) 742–748. [DOI] [PubMed] [Google Scholar]
  • [76].Audebert HJ, Schultes K, Tietz V, Heuschmann PU, Bogdahn U, Haberl RL, et al. , Telemedical project for integrative stroke care (TEMPiS). Long-term effects of specialized stroke care with telemedicine support in community hospitals in behalf of the Telemedical project for integrative stroke care (TEMPiS), Stroke 40 (2009) 902–908. [DOI] [PubMed] [Google Scholar]
  • [77].Audebert HJ, Kukla C, Clarmann von Claranau S, Kuhn J, Vatankhah B, Schenkel J, et al. , TEMPiS Group, Telemedicine for safe and extended use of thrombolysis in stroke: the Telemedic Pilot Project for Integrative Stroke Care (TEMPiS) in Bavaria, Stroke 36 (2005) 287–291. [DOI] [PubMed] [Google Scholar]
  • [78].Rasmusson KA, Hartshorn JC, A comparison of epilepsy patients in a traditional ambulatory clinic and a telemedicine clinic, Epilepsia 5 (2005) 767–770. [DOI] [PubMed] [Google Scholar]
  • [79].Loh PK, Telemedicine and Alzheimer’s disease from studio-based videoconferencing to mobile handheld cell phones, J. Brain Dis 1 (2009) 39–43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [80].Cottrell C, Drew J, Gibson J, Holroyd K, O’Donnell F, Feasibility assessment of telephone-administered behavioral treatment for adolescent migraine, Headache 47 (2007) 1293–1302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [81].Samii A, Ryan-Dykes P, Tsukuda RA, Zink C, Franks R, Nichol WP, Telemedicine for delivery of health care in Parkinson’s disease, J. Telemed. Telecare 12 (2006) 16–18. [DOI] [PubMed] [Google Scholar]
  • [82].Kane RL, Bever CT, Ehrmantraut M, Forte A, Culpepper WJ, Wallin MT, Teleneurology in patients with multiple sclerosis: EDSS rating derived remotely and from hands-on examination, J. Telemed. Telecare 14 (2008) 190–194. [DOI] [PubMed] [Google Scholar]
  • [83].Sarfo FS, Treiber F, Jenkins C, Patel S, Gebregziabher M, Singh A, et al. , Phone-based Intervention under Nurse Guidance after Stroke (PINGS): study protocol for a randomized controlled trial, Trials 17 (1) (2016) 436. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [84].Sarfo F, Treiber F, Gebregziabher M, Adamu S, Patel S, Nichols M, et al. , PINGS (Phone-based Intervention under Nurse Guidance after Stroke): interim results of a pilot randomized controlled trial, Stroke 49 (1) (2018) 236–239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [85].Sarfo FS, Treiber F, Gebregziabher M, Adamu S, Nichols M, Singh A, et al. , Phone-based intervention for blood pressure control among Ghanaian stroke survivors: a pilot randomized controlled trial, Int. J. Stroke 22 (November, 2018) (1747493018816423). [DOI] [PubMed] [Google Scholar]
  • [86].Sarfo FS, Adamu S, Awuah D, Sarfo-Kantanka O, Ovbiagele B, Potential role of tele-rehabilitation to address barriers to implementation of physical therapy among West African stroke survivors: a cross-sectional survey, J. Neurol. Sci 381 (2017) 203–208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [87].Sarfo FS, Ovbiagele B, Response by Sarfo and Ovbiagele to letter regarding “potential role of tele-rehabilitation to address barriers to implementation of physical therapy among west African stroke survivors: a cross-sectional survey”, J. Neurol. Sci 382 (2017) 162–163. [DOI] [PubMed] [Google Scholar]
  • [88].Sarfo FS, Ulasavets U, Opare-Sem OK, Ovbiagele B, Tele-rehabilitation after stroke: an updated systematic review of the literature, J. Stroke Cerebrovasc. Dis 27 (9) (2018) 2306–2318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [89].Sarfo FS, Adusei N, Ampofo M, Kpeme FK, Ovbiagele B, Pilot trial of a telerehab intervention to improve outcomes after stroke in Ghana: a feasibility and user satisfaction study, J. Neurol. Sci 387 (2018) 94–97. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [90].Sarfo FS, Ovbiagele B, Stroke minimization through additive anti-atherosclerotic agents in routine treatment (SMAART): a pilot trial concept for improving stroke outcomes in sub-Saharan Africa, J. Neurol. Sci 377 (2017) 167–173. [DOI] [PubMed] [Google Scholar]
  • [91].Sarfo FS, Sarfo-Kantanka O, Adamu S, Obese V, Voeks J, Tagge R, et al. , Stroke Minimization through Additive Anti-atherosclerotic Agents in Routine Treatment (SMAART): study protocol for an randomized controlled trial, Trials 19 (1) (2018) 181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [92].Whittaker JA, Montgomery BL, Martinez Acosta VG, Retention of underrepresented minority faculty: strategic initiatives for institutional value proposition based on perspectives from a range of academic institutions, J. Undergrad. Neurosci. Educ 13 (2015) A136–A145. [PMC free article] [PubMed] [Google Scholar]
  • [93].Rust G, Cooper LA, How can practice-based research contribute to the elimination of health disparities? J. Am. Board Fam. Med 20 (2007) 105–114. [DOI] [PubMed] [Google Scholar]
  • [94].Ovbiagele B, Jenkins C, Patel S, Brunner-Jackson B, Anderson A, Saulson R, et al. , Mobile health medication adherence and blood pressure control in recent stroke patients, J. Neurol. Sci 358 (2015) 535–537. [DOI] [PubMed] [Google Scholar]

RESOURCES